These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21686214)

  • 1. Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics.
    Stephens DS
    Trans Am Clin Climatol Assoc; 2011; 122():115-23. PubMed ID: 21686214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial meningitis: the impact of vaccination.
    Makwana N; Riordan FA
    CNS Drugs; 2007; 21(5):355-66. PubMed ID: 17447825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aspects of prevention and therapy of meningitis.
    Kaplan SL
    Infect Dis Clin North Am; 1992 Mar; 6(1):197-214. PubMed ID: 1578118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in bacterial conjugate vaccines.
    Goldblatt D
    J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM; Djingarey M; Viviani S; Preziosi MP
    Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.
    Pichichero ME
    Hum Vaccin Immunother; 2013 Dec; 9(12):2505-23. PubMed ID: 23955057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of bacterial meningitis.
    Peltola H
    Infect Dis Clin North Am; 1999 Sep; 13(3):685-710, viii. PubMed ID: 10470562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of conjugate vaccines to prevent meningitis caused by Haemophilus influenzae type b or Streptococcus pneumoniae.
    Eskola J
    J Hosp Infect; 1995 Jun; 30 Suppl():313-21. PubMed ID: 7560967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards meningitis prevention in the conjugate vaccines era.
    Laval CA; Pimenta FC; de Andrade JG; Andrade SS; de Andrade AL
    Braz J Infect Dis; 2003 Oct; 7(5):315-24. PubMed ID: 14552741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vaccines on bacterial meningitis worldwide.
    McIntyre PB; O'Brien KL; Greenwood B; van de Beek D
    Lancet; 2012 Nov; 380(9854):1703-11. PubMed ID: 23141619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MenHibrix: a new combination meningococcal vaccine for infants and toddlers.
    Hale SF; Camaione L; Lomaestro BM
    Ann Pharmacother; 2014 Mar; 48(3):404-11. PubMed ID: 24353263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
    Trotter CL; Gay NJ; Edmunds WJ
    Am J Epidemiol; 2005 Jul; 162(1):89-100. PubMed ID: 15961591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise of conjugate vaccines for Africa.
    Kieny MP; LaForce FM
    Vaccine; 2007 Sep; 25 Suppl 1():A108-10. PubMed ID: 17548136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapies and vaccines for bacterial meningitis.
    Foster C; Nadel S
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1051-60. PubMed ID: 12150701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugates and reverse vaccinology to eliminate bacterial meningitis.
    Rappuoli R
    Vaccine; 2001 Mar; 19(17-19):2319-22. PubMed ID: 11257355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.